本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mira Pharma

1.22
-0.0300-2.40%
盤後1.17-0.0500-4.10%19:58 EDT
成交量:20.88萬
成交額:24.81萬
市值:2,051.27萬
市盈率:-2.40
高:1.25
開:1.25
低:1.17
收:1.25
資料載入中...
2024/01/17

重要事件披露

Form 8-K - Current report
2023/12/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/22

SEC問詢函

Form CORRESP - Correspondence
2023/12/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/20

重要事件披露

Form 8-K - Current report
2023/11/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/14

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/31

SEC問詢函

Form CORRESP - Correspondence
2023/07/31

SEC問詢函

Form CORRESP - Correspondence
2023/07/29

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/25

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/21

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/18

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]